Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
914.50
Change Change %
-9.95 -1.08%

Updated:23 May, 2019, 14:44 PM IST

BSE
913.15
Change Change %
-8.35 -0.91%

Updated:23 May, 2019, 15:21 PM IST

Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

905.00 936.85

52 Wk Range

599.95 1046.00
Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

907.70931.45

52 Wk Range

590.10 1042.00

Compare Price performance of vs. Peer Companies

From sector

Compare with Peers on Key Fundamentals and Financials

Color code for Price performance of and Peer companies

  • 5% and above
  • 2% to 5%
  • 0.5% to 2%
  • -0.5% to 0.5%
  • -2% to -0.5%
  • -5% to -2%
  • -5% and below
 

's Latest Research Report

Brokerage/Analyst Report Date Call Price@Call Target Current Status Report
Yes Securities
-
14-02-2019 Buy 745.15 950.00 Closed Details
Edelweiss
-
16-11-2017 Sell 533.75 440.00 Closed Details
UBS
-
11-04-2017 Hold 636.90 675.00 Target Hit Details
Edelweiss
-
18-11-2016 Sell 545.00 420.00 Target Hit Details
Angel Broking
-
17-11-2016 Buy 534.20 613.00 Target Hit Details

More from Research Reports »

Ipca Laboratories's Key Fundamentals

Parameter Values
Market Cap (in ₹ Cr.) 11,554.89
Earning Per Share (EPS TTM) (₹) 41.12
Price To Earnings (P/E) Ratio 22.24
Book Value Per Share (₹) 213.52
Price To Books (P/B) Ratio 4.28
EBIT Margin (%) 9.64
PAT Margin (%) 7.24
ROCE (%) 9.53
PAT Growth (%) 23.80
Total Debt to Equity (D/E) Ratio 0.23

More from Key Fundamentals »

Ipca Laboratories's Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
YoY
%Change
Balance Sheet:
Share Capital 25.24 25.24 0.00%
Total Non-Current Liabilities 420.11 546.49 -23.13%
Total Current Liabilities 992.65 946.34 4.89%
Total Liabilities 4,107.70 3,967.95 3.52%
Total Non-Current Assets 2,200.53 2,256.30 -2.47%
Currents Investments 69.35 113.57 -38.94%
Cash and Bank 131.03 17.53 647.46%
Total Current Assets Excluding Current Investments 1,837.82 1,598.08 15.00%
Total Assets 4,107.70 3,967.95 3.52%
Profit and Loss:
Gross Sales 3,219.21 3,158.22 1.93%
Net Sales 3,193.40 3,102.21 2.94%
PBIDT (Excl OI) 426.92 398.67 7.09%
PAT 233.11 188.29 23.80%

More from Financial Summary »

Ipca Laboratories's Shareholding Pattern

..

Post your comments about Ipca Laboratories

Top